Evidence map›Paper›PMID 25888031›Full record

Observational studyBMC infectious diseases2015

New echinocandin susceptibility patterns for nosocomial Candida albicans in Bogotá, Colombia, in ten tertiary care centres: an observational study.

Giovanni Rodríguez-Leguizamón, Alessandro Fiori, Katrien Lagrou, María Antonia Gaona, Milciades Ibáñez, Manuel Alfonso Patarroyo, Patrick Van Dijck, Arley Gómez-López

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in BMC infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Microorganisms · 2024
    Article
  2. Article
  3. Candidemia in ColombiaBiomedica : revista del Instituto Nacional de Salud · 2020
    Article
  4. Robust, Comprehensive Molecular, and Phenotypical Characterisation of AtypicalFrontiers in cellular and infection microbiology · 2020
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Giovanni Rodríguez-LeguizamónSchool of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia. giovanni.rodriguez@urosario.edu.co.
Alessandro FioriVIB Department of Molecular Microbiology, KU Leuven, Leuven, Belgium. alessandro.fiori@mmbio.vib-kuleuven.be.
Katrien LagrouDepartment of Microbiology and Immunology, KU Leuven, Leuven, Belgium. katrien.lagrou@med.kuleuven.be.
María Antonia GaonaFaculty of Natural and Mathematical Sciences, Universidad del Rosario, Bogotá, Colombia. magaona@urosario.edu.co.
Milciades IbáñezSchool of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia. mippalad@yahoo.com.
Manuel Alfonso PatarroyoSchool of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia. mapatarr.fidic@gmail.com.
Patrick Van DijckVIB Department of Molecular Microbiology, KU Leuven, Leuven, Belgium. patrick.vandijck@mmbio.vib-kuleuven.be.
Arley Gómez-LópezMolecular Biology and Immunology Department, Fundación Instituto de Inmunología de Colombia (FIDIC), Carrera 50#26-20, Bogotá, Colombia. arley.gomez.lo@gmail.com.
Universidad del Rosario · COVIB-KU Leuven Center for Microbiology · BEFundación Instituto de Inmunología de Colombia · COKU Leuven · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCandida albicans remains as the first cause of nosocomial fungal infections in hospitals worldwide and its susceptibility pattern should be better described in our tertiary care hospitals.

methodsThis study aimed at identifying the caspofungin susceptibility pattern regarding nosocomial Candida albicans infection in ten tertiary care hospitals using the methodology proposed by CLSI M27-A3 and CLSI M27-S4, and its association with risk factors and clinical outcome. The approach involved descriptive research concerning the diagnosis of nosocomial infection during a 7-month period in 10 hospitals in Bogotá, Colombia. Associations were established using exact non-parametric statistical tests having a high statistical power (>95%), suitable for small samples. The exact Mann Whitney test or Kruskall-Wallis non-parametric ANOVA tests were used for distributions which were different to normal or ordinal variables when comparing three or more groups. Multivariate analysis involved using binomial, multinomial and ordinal exact logistical regression models (hierarchical) and discrimination power was evaluated using area under the ROC curve.

results101 nosocomial infections were found in 82,967 discharges, for a Candida spp. infection rate of 12.2 per 10,000 discharges, 30.7% caused by C. albicans, 22.8% by C. tropicalis, 20.8% by C. parapsilosis, 19.8% by other Candida, 3% by C. krusei and 3% by C. glabrata. Statistically significant associations between mortality rate and the absence of parenteral nutrition were found in multivariate analysis (OR = 39.746: 1.794-880.593 95% CI: p = 0.020). The model's predictive power was 83.9%, having an 85.9% significant prediction area (69.5%-100 95% CI; p = 0.001).

conclusionsSignificant differences were found regarding susceptibility results when comparing CLSI M27-A3 to CLSI M27-S4 when shifting clinical break-point values. However, one nosocomial strain was consistent in having reduced susceptibility when using both guidelines without having been directly exposed to echinocandins beforehand and no mutations were found in the FKS1 gene for hot spot 1 and/or hot spot 2 regions, thereby highlighting selective pressure regarding widespread antifungal use in tertiary healthcare centres. Nutritional conditions and low family income were seen to have a negative effect on survival rates.

Indexed as

AdolescentAdultAgedAged, 80 and overAntifungal AgentsCandida albicansCandidiasisCaspofunginChildChild, PreschoolColombiaCross InfectionEchinocandinsFemaleHumansInfantAntifungal AgentsCaspofunginEchinocandinsLipopeptides

Identifiers

PMID25888031
PMCPMC4359562
OpenAlexW2085937510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.